NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
ImpediMed Limited (PINK: IPDQF)
IPDQF Technical Analysis
5
As on 18th Nov 2024 IPDQF STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.10 & Strong Sell for SHORT-TERM with Stoploss of 0.12 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IPDQFSTOCK Price
Open | 0.03 | Change | Price | % |
High | 0.03 | 1 Day | -0.02 | -40.00 |
Low | 0.03 | 1 Week | -0.03 | -50.00 |
Close | 0.03 | 1 Month | -0.02 | -40.00 |
Volume | 50000 | 1 Year | -0.08 | -72.73 |
52 Week High 0.15 | 52 Week Low 0.02 |
PINK USA Most Active Stocks
TXGE | 2496.74 | -1.63% |
CYBL | 0.01 | % |
CLNV | 0.02 | 0.00% |
WRFX | 0.01 | % |
AMXVF | 1.05 | 10.53% |
VDRM | 0.01 | % |
AABB | 0.03 | 0.00% |
ICBU | 0.01 | % |
APLD | 8.77 | -1.68% |
HTZZ | 24.68 | 1.52% |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
IPDQF Daily Charts |
IPDQF Intraday Charts |
Whats New @ Bazaartrend |
IPDQF Free Analysis |
|
IPDQF Important Levels Intraday
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
IPDQF Forecast November 2024
4th UP Forecast | 0.13 |
3rd UP Forecast | 0.1 |
2nd UP Forecast | 0.08 |
1st UP Forecast | 0.06 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | -0.02 |
3rd DOWN Forecast | -0.04 |
4th DOWN Forecast | -0.07 |
IPDQF Weekly Forecast
4th UP Forecast | 0.05 |
3rd UP Forecast | 0.04 |
2nd UP Forecast | 0.04 |
1st UP Forecast | 0.04 |
1st DOWN Forecast | 0.02 |
2nd DOWN Forecast | 0.02 |
3rd DOWN Forecast | 0.02 |
4th DOWN Forecast | 0.01 |
IPDQF Forecast2024
4th UP Forecast | 0.28 |
3rd UP Forecast | 0.2 |
2nd UP Forecast | 0.15 |
1st UP Forecast | 0.1 |
1st DOWN Forecast | -0.04 |
2nd DOWN Forecast | -0.09 |
3rd DOWN Forecast | -0.14 |
4th DOWN Forecast | -0.22 |
ImpediMed Limited ( PINK USA Symbol : IPDQF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IPDQF Other Details
Segment | EQ | |
Market Capital | 202027792.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
IPDQF Address
IPDQF Latest News
IPDQF Business Profile
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was incorporated in 1999 and is headquartered in Pinkenba, Australia. Address: 50 Parker Court, Pinkenba, QLD, Australia, 4008
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service